Remibrutinib Alleviates Atopic Dermatitis via Downregulation of Keratinocyte-Derived TSLP and Th2 Immune Activation
Fields of Study & Subjects
Dermatology and Skin Diseases
Asthma and respiratory diseases
Psoriasis: Treatment and Pathogenesis
Publication details
- Journal / source
- Journal of Allergy and Clinical Immunology
- Volume
- 157
- Issue
- 2
- Pages
- AB29–AB29
- Publication date
- 1 February 2026
- Language
- EN